Trends in pharmacological sciences

• 

  Año 2006, Vol. 27, Número 9

  • Intracellular 5-HT_2C-receptor dephosphorylation: a new target for treating drug addiction

    Robert J. Carey, Christian P. Müller

    págs. 455-458

    

  • GPCR antagonists as an alternative to COX-2 inhibitors: a case for the PGE₂ EP₁ receptor

    Sylvain Doré

    págs. 458-460

    

  • Resolution of airway disease: removal of inflammatory cells through apoptosis, egression or both?

    Carl G.A. Persson, Jonas S. Erjefält, Lena Uller

    págs. 461-466

    

  • Analgesic strategies beyond the inhibition of cyclooxygenases

    Kay Brune, Hanns Ulrich Zeilhofer

    págs. 467-474

    

  • Allosteric agonists of 7TM receptors: expanding the pharmacological toolbox

    Christopher J. Langmead, Arthur Christopoulos

    págs. 475-481

    

  • Brain nicotinic acetylcholine receptors: native subtypes and their relevance

    Cecilia Gotti, Francesco Clementi, Michele Zoli

    págs. 482-491

    

  • Rho kinase: a target for treating urinary bladder dysfunction?

    Martina Schmidt, Martin C. Michel, Stephan L.M. Peters

    págs. 492-497

    

  • Applying pharmacogenomics to enhance the use of biomarkers for drug effect and drug safety

    Howard L. McLeod, Amber L. Beitelshees

    págs. 498-502

    

  • Methodological issues in the assessment of skin microvascular endothelial function in humans

    John R. Halliwill, Christopher T. Minson, Muriel Salvat-Melis, Jean-Luc Cracowski

    págs. 503-508